Reader Comments
Post a new comment on this article
Post Your Discussion Comment
Please follow our guidelines for comments and review our competing interests policy. Comments that do not conform to our guidelines will be promptly removed and the user account disabled. The following must be avoided:
- Remarks that could be interpreted as allegations of misconduct
- Unsupported assertions or statements
- Inflammatory or insulting language
Thank You!
Thank you for taking the time to flag this posting; we review flagged postings on a regular basis.
closeMedia coverage of this article
Posted by PLOS_ONE_Group on 16 Aug 2013 at 18:25 GMT
The following article represents some of the media coverage that has occurred for this paper:
Publication: Forbes
Title: “Possible Efficacy Of Lilly's Necitumumab (IMC-11F8) In Lung Cancer Subset - Forbes”
http://www.forbes.com/sit...
If you see any additional coverage of this paper in the press or blogosphere, please reply to this thread and add the link to the article.
Media coverage of this article
PLOS_ONE_Group replied to PLOS_ONE_Group on 23 Aug 2013 at 17:46 GMT
The following article represents some of the media coverage that has occurred for this paper:
Publication: Forbes
Title: “Possible Efficacy Of Lilly's Necitumumab (IMC-11F8) In Lung Cancer Subset”
http://www.forbes.com/sit...
If you see any additional coverage of this paper in the press or blogosphere, please reply to this thread and add the link to the article.